Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Allotrope Foundation Reaches First Major Milestone in Development of Laboratory Information Framework and Launch of Partner Network

Published: Sunday, March 30, 2014
Last Updated: Sunday, March 30, 2014
Bookmark and Share
Allotrope Foundation aims to make the intelligent analytical laboratory a reality.

Allotrope Foundation, a consortium of pharmaceutical and biotech companies, has reached the first major milestone in the development of its innovative laboratory information Framework and announced the launch of a partner network to encourage further collaboration.

In just six months, the Foundation has gone from concept to implementation of its first Proof of Concept (PoC) application using the open Framework that will manage analytical data throughout its complete lifecycle using a common set of standard tools.

Allotrope has also established a Partner Network, designed to enable and encourage collaboration with the instrument and software vendor community in developing the Framework.

“The deployment of the first Proof of Concept is a significant milestone on our development roadmap”, said Wolfgang Colsman, CTO of Osthus GmbH and lead architect of the Allotrope Framework. “In about six months of development, we were able to go from an idea to a working implementation.”

Allotrope Foundation aims to make the intelligent analytical laboratory a reality – an automated laboratory where data, methods and hardware components are seamlessly shared between disparate platforms, and where one-click reports can be produced using data generated on any analytical instrument. The Proof of Concept now deployed addresses experiment initiation and data acquisition using instruments from multiple vendors (standard instrument input-output). This PoC also demonstrates the seamless exchange of analytical data between software applications from different vendors. This state-of-the-art data exchange demonstrates several new capabilities, including the simple exchange of data between an Allotrope member and a business partner, for example, a CRO.

“I am really excited to be part of this historic event and of our contribution to bringing the longstanding vision of the intelligent analytical lab one step closer to a reality,” said Janet Cheetham, Executive Director, Analytical Research and Development at Amgen and Board Member of Allotrope. “Seeing the Framework perform as expected in one of our own laboratories validates the core fundamentals of Allotrope’s approach to solving many of the current pain points we are experiencing today with analytical data management in Pharma Biotech and in many other industries that have analytical labs.”

“From the onset of Allotrope Foundation, we’ve been focused on building a sustainable Framework that will enhance how we produce and consume analytical data,” said James Roberts, Senior Scientific Investigator, Analytical Development at GlaxoSmithKline (GSK) and co-lead of the Allotrope Foundation Core Technical Team. “Using the Framework to embed open standards in our labs, running real experiments in 2014, is the first step to enhancing efficiency, facilitating data exchange and enabling automation.”

The successful deployment of a Proof of Concept also triggers the launch of Allotrope’s Partner Network, which is designed to give all software and hardware vendors an opportunity to provide direct feedback to Allotrope Foundation regarding the Framework.

“We took great care to design a Partner Network that enables all interested vendors to provide feedback on the Framework,” said Gordon Hansen, VP Analytical Development, US and Chairman of Allotrope Foundation Board of Directors. “There has been strong interest from the vendor community in working with us, and we are thrilled to open the doors to such a collaboration.”

As part of the Partner Network, Allotrope provides access to pre-release software, documentation, interfaces and test data.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!